Today: 21 May 2026
Big Tech stocks slide into Presidents Day break — Apple, Nvidia drag and key dates loom

Big Tech stocks slide into Presidents Day break — Apple, Nvidia drag and key dates loom

New York, February 15, 2026, 12:52 (EST) — The market has closed.

  • Big Tech stumbled late last week, with investors scrutinizing whether the recent surge in AI outlays will actually deliver returns.
  • Apple and Nvidia dragged down the “Magnificent Seven” on Friday, leading the day’s losses.
  • U.S. markets return to action Tuesday, with Fed minutes and Nvidia results lined up next.

The Roundhill Magnificent Seven ETF slipped 1.1% Friday, capping a tough week for Big Tech names. Apple closed off 2.3% at $255.78, with Nvidia not far behind, down 2.2% to $182.81. Meta gave up 1.5% and Alphabet lost 1.1%.

This comes as the market’s heavyweight names are getting shaky ahead of the three-day U.S. holiday stretch. The Nasdaq slipped 0.22% by Friday’s close, shrugging off a surprisingly mild January inflation report. All the major indexes just saw their biggest weekly declines since November. “Large cap tech stocks continue to be an anchor on the market,” said Michael James, managing director at Rosenblatt Securities, as traders pulled back before the long weekend. Reuters

The real fight? It’s about artificial intelligence, and how much it’s actually worth. Investors are still trying to digest just how much cash the biggest tech names are throwing at AI. Amazon, Google, Meta, and Microsoft together are on track to pour around $650 billion into the push for AI supremacy, according to Reuters. Jack Herr, primary investment analyst at GuideStone Funds, described 2026 as a “prove it” year for AI—markets want payback on all that spending. Reuters

Late in the week, selling picked up speed. Cisco spooked the market with warnings about margin pressure from skyrocketing memory-chip costs, according to Reuters’ Morning Bid column. Apple dropped 5% in a single session, erasing roughly $200 billion in market cap in the process—a jolt for anyone betting size alone keeps stocks steady when the AI story sours.

Turns out, the jitters have seeped beyond tech’s borders. Reuters flagged an “AI scare trade” breaking out after Anthropic launched its legal AI plug-in, with the first hit landing on software—then the selloff rippling outward into sectors considered at risk from automation. Barclays equity strategist Emmanuel Cau saw investors spooked into what he called “sell first think later” territory. Reuters

A few corporate stories pulled in the opposite direction. Microsoft and Ericsson rolled out a “Trusted Tech Alliance” on Friday, aiming to set ground rules for safe tech use, wherever the code originates. Amazon Web Services and Alphabet’s Google are also on board. Microsoft President Brad Smith told Reuters that governments are increasingly pushed toward “stronger technology borders” and prioritizing digital sovereignty. Reuters

Regulators aren’t sitting this one out. The U.S. Federal Trade Commission has ramped up its probe into Microsoft, reaching out to competitors about licensing terms and other business moves, Bloomberg News reported via Reuters. In addition, the agency wants details on how Microsoft bundles AI tools, security, and identity products, the report noted.

Investors are looking ahead to Wednesday, when the Federal Reserve will publish minutes from its Jan. 27-28 meeting. Interest-rate chatter often rattles tech stocks, whose valuations hinge on expectations for future earnings.

Nvidia’s on deck: the chipmaker plans a conference call this Wednesday, Feb. 25, at 2 p.m. PT (5 p.m. ET), according to its news release. It’ll go over fourth-quarter numbers, but investors are expected to zero in on guidance—and whether demand for AI infrastructure is still powering actual orders.

Still, the downside risk hasn’t left the market. Fresh supplier cost alerts, more aggressive regulatory headlines, or even a change in tone from the Fed minutes—all of that could send bond yields higher and keep the squeeze on high-priced Big Tech stocks.

Tuesday’s open puts the focus on the Magnificent Seven: Will dip buyers step back in after the long weekend, or does the next leg down hold out for the Feb. 18 Fed minutes and Nvidia’s report on Feb. 25?

Stock Market Today

  • JPMorgan's Foley Predicts Strong IPO Growth in Hong Kong and China
    May 21, 2026, 3:16 AM EDT. Kevin Foley, Co-Head of Global Investment Banking at JPMorgan, forecasts robust initial public offering (IPO) activity growth in Hong Kong and mainland China, driven by sectors like artificial intelligence (AI) and healthcare. Despite ongoing higher interest rates and inflationary pressures, he notes that global deal-making remains strong. Foley made these remarks during the JPMorgan Global China Summit, emphasizing the resilience in equity markets and the importance of these sectors in upcoming market offerings.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week
Previous Story

Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week

Micron stock price in focus as India start-up timeline lands on a US market holiday
Next Story

Micron stock price in focus as India start-up timeline lands on a US market holiday

Go toTop